Lulu Long
- Cancer Research top 5%
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 4
-
- RNA modifications and cancer 2
- Circular RNAs in diseases 2
- Cell death mechanisms and regulation 1
-
- Natural Compounds in Disease Treatment 3
-
- Drug Transport and Resistance Mechanisms 2
-
- Nanoparticle-Based Drug Delivery 1
- Partner nations
- ChinaTürkiyeUnited States
In The Last Decade
Lulu Long
10 papers receiving 488 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 348
- Molecular Biology 401
- Complementary and alternative medicine 30
- Oncology 59
- Toxicology 5
Countries citing papers authored by Lulu Long
This map shows the geographic impact of Lulu Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lulu Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lulu Long more than expected).
Fields of papers citing papers by Lulu Long
This network shows the impact of papers produced by Lulu Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lulu Long. The network helps show where Lulu Long may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lulu Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 12 | |
| 2 | 2017 | 59 | |
| 3 | 2013 | 59 | |
| 4 | 2012 | 48 | |
| 5 | 2012 | 28 | |
| 6 | 2012 | 152 | |
| 7 | 2012 | 105 | |
| 8 | [Effect of triptolide on sensitivity of K562/A02 cell line to adriamycin]. | 2012 | 1 |
| 9 | 2012 | 4 | |
| 10 | 2011 | 23 |
About Lulu Long
Lulu Long is a scholar working on Cancer Research, Complementary and alternative medicine and Small Animals, having authored 10 papers that have together received 491 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (4 papers), Natural Compounds in Disease Treatment (3 papers), RNA modifications and cancer (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Circular RNAs in diseases (2 papers), Cell death mechanisms and regulation (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Cancer Research (348 citations), Molecular Biology (401 citations) and Complementary and alternative medicine (30 citations). Lulu Long has collaborated with scholars based in China, Türkiye and United States. Frequent co-authors include Xiaolan Zhu, Wenlin Xu, Huiling Shen, Lulu Hui, Yuefeng Li, Hao Li, Hao Li, Hai‐Ning Chen, Xuefeng Wang and Hao Li. Their work appears in journals such as Acta Biochimica et Biophysica Sinica, FEBS Letters, Oncotarget, The FASEB Journal and Journal of Ovarian Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.